Table 1 Baseline characteristics of study participants
Variable | AWT (n = 12) mean ± SD | AWT + CM (n = 14) mean ± SD | Control (n = 14) mean ± SD | p-value |
|---|---|---|---|---|
Age (years) | 72.08 ± 10.88 | 73.50 ± 10.73 | 67.79 ± 9.98 | 0.335 |
Sex (male/female) | 6/6 | 8/6 | 8/6 | 0.917 |
Weight (kg) | 60.40 ± 15.91 | 66.43 ± 14.48 | 58.89 ± 9.66 | 0.424 |
Body Mass Index (BMI) | 22.29 ± 4.69 | 25.21 ± 5.03 | 22.82 ± 3.05 | 0.258 |
Total duration of MV (days) | 34.83 ± 18.52 | 37.36 ± 15.25 | 40.57 ± 16.91 | 0.550 |
Ventilator days during RCC (days) | 14.08 ± 12.44 | 19.14 ± 12.76 | 21.29 ± 14.55 | 0.381 |
Length of stay during RCC (days) | 19.33 ± 11.59 | 24.21 ± 11.81 | 25.50 ± 12.88 | 0.331 |
Mortality prediction | ||||
Charlson Comorbidity Index, CCI | 6.83 ± 1.64 | 7.00 ± 2.69 | 6.36 ± 2 .76 | 0.688 |
APACHE II score | 14.58 ± 3.66 | 15.21 ± 2.81 | 14.07 ± 2.95 | 0.673 |
Artificial airway, n (%) | ||||
APACHE II score | 9 (75.0) | 11 (78.6) | 8 (57.1) | 0.420 |
Tracheostomy | 3 (25.0) | 3 (21.4) | 6 (42.9) | |
Primary problems at admission to RCC, n (%) | ||||
Pulmonary diseases | 4 (33.3) | 7 (50.0) | 7 (50.0) | 0.687 |
Cardiovascular diseases | 5 (41.7) | 3 (21.4) | 3 (21.4) | |
Neuromuscular diseases | 3 (25.0) | 3 (21.4) | 2 (14.3) | |